ATR and neoplasm: Non-malignant cells possess a functional G1-checkpoint, in contrast to most NSCLC cells, it is proposed that selective tumor radiosensitization can be achieved by abrogation of the G2-checkpoint using inhibitors of ATM or ATR [47].